| Patent Number | Grant Date | Title | Applicant |
|---|---|---|---|
| EP2819699 | Oct 16, 2024 | Controlled Release Compositions And Their Methods Of Use | BAYER NEW ZEALAND LIMITED |
| EP3045466 | Oct 16, 2024 | (2S,3R,4S,5S,6R)-2-[4-Chloro-3-(4-Ethoxy-Benzyl)-Phenyl]-6-Hydroxymethyl-2-Methoxy-Tetrahydro-Pyran-3,4,5-Triol Propylene Glycol Solvate As Sgt2 Inhibitor For The Treatment Of Diabetes | ASTRAZENECA AB |
| EP3218406 | Oct 2, 2024 | Binding Molecules Specific For Cd73 And Uses Thereof | MEDIMMUNE LIMITED |
| EP3200591 | Sep 25, 2024 | Central Memory T Cells For Adoptive T Cell Therapy | CITY OF HOPE |
| EP3035951 | Sep 4, 2024 | Beta-Casein A2 And Blood Glucose Levels | THE A2 MILK COMPANY LIMITED |
| EP2736487 | Aug 28, 2024 | New (Trimethoxyphenylamino)Pyrimidinyl Formulations | RIGEL PHARMACEUTICALS, INC. |
| EP3076983 | Aug 14, 2024 | Ionic Aqueous Compositions | GEROLYMATOS INTERNATIONAL S.A. |
| EP2694072 | Aug 7, 2024 | Combinations Of Akt Inhibitor Compounds And Abiraterone, And Methods Of Use | GENENTECH, INC. |
| EP3206987 | Jul 24, 2024 | Nanoparticles For Photodynamic Therapy, X-Ray Induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, And Any Combination Thereof | THE UNIVERSITY OF CHICAGO |
| EP3102208 | Jul 17, 2024 | Crystalline Polymorphs Of The Free Base Of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde | GLOBAL BLOOD THERAPEUTICS, INC. |
| Patent Number | Grant Date | Title | Applicant | Facing Oppositions |
|---|---|---|---|---|
| EP3391890 | Aug 25, 2021 | Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta Cyclodextrin | MERCK SHARP & DOHME CORP. | 96 |
| EP2397155 | Dec 13, 2017 | Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd 1)Pathway | DANA-FARBER CANCER INSTITUTE, INC. | 54 |
| EP3351246 | Sep 18, 2019 | Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated Angiogenesis | NOVARTIS PHARMA AG | 54 |
| EP2397142 | Jul 27, 2022 | Use Of Dpp Iv Inhibitors | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | 50 |
| EP2780375 | Sep 11, 2019 | Binding Molecules For Bcma And Cd3 | AMGEN INC. | 48 |
| EP2478907 | Apr 14, 2021 | Methods And Compositions For Treating Cancer | COUGAR BIOTECHNOLOGY, INC. | 44 |
| EP2913327 | Jun 7, 2023 | Methylene Blue And Its Medical Use | PROVENCE TECHNOLOGIES | 42 |
| EP2780374 | Aug 21, 2019 | Binding Molecules For Bcma And Cd3 | AMGEN RESEARCH (MUNICH) GMBH | 42 |
| EP2791160 | Mar 2, 2022 | Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions | MODERNATX, INC. | 40 |
| EP4008357 | Dec 28, 2022 | Small Liposomes For Delivery Of Immunogen Encoding Rna | GLAXOSMITHKLINE BIOLOGICALS SA | 40 |
Feel free to send us a message here and we will get back to you